Vesalio announces oversubscribed Class A financing
Vesalio, an emerging leader in improving outcomes in patients with vascular occlusion, is proud to announce it has oversubscribed its Class A financing round.
Vesalio Announces Completion of Enrollment in its FDA Enabling Stroke Study
Vesalio announces the completion of enrollment in its FDA IDE clinical study for acute ischemic stroke.
VESALIO ENVAST BRANDING RESOURCES
Brand guidelines to show the Vesalio brand is to be used and presented to the public.
